Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
PreventionGenetics, part of Exact Sciences United States | 10 | 9 |
|
Invitae Metabolic Newborn Screening Confirmation Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 201 | 158 |
|
Invitae Elevated Phenylalanine (Hyperphenylalaninemia) Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 10 | 8 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 9 | 7 |
|
SLC25A13 Comprehensive - Sequence & Deletion/Duplication Analysis Baylor Genetics United States | 2 | 1 |
|
SLC25A13 Sequence Analysis (Prenatal Diagnosis) Baylor Genetics United States | 2 | 1 |
|
SLC25A13 Deletion/Duplication Analysis Baylor Genetics United States | 2 | 1 |
|
Baylor Genetics United States | 2 | 1 |
|
Baylor Genetics United States | 25 | 26 |
|
Inherited Metabolic Disorders Panel Dhiti Omics Technologies Private Ltd India | 376 | 317 |
|
Cholestasis panel. NGS panel of 46 genes. Genologica Medica Spain | 88 | 46 |
|
Hyperammonemia and urea cycle disorders panel. 48-gene NGS panel. Genologica Medica Spain | 49 | 48 |
|
Citrullinemia: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 3 | 2 |
|
Mitochondrial genome sequencing Molecular Vision Laboratory United States | 525 | 339 |
|
Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 104 | 73 |
|
Mitochondrial Panel, Nuclear genes CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 145 | 134 |
|
Comprehensive Metabolism NGS Panel Fulgent Genetics United States | 602 | 355 |
|
Hyperammonemia and Urea Cycle Disorder NGS Panel Fulgent Genetics United States | 70 | 56 |
|
Beacon Expanded Female Carrier Screening Plus Panel Fulgent Genetics United States | 716 | 335 |
|
Beacon Expanded Male Carrier Screening Panel Fulgent Genetics United States | 636 | 298 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.